{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:45:46Z","timestamp":1780735546863,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.breast.2022.12.010","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T05:31:28Z","timestamp":1671514288000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["\u201cThis house believes that: Sentinel node biopsy alone is better than TAD after NACT for cN+ patients\u201d"],"prefix":"10.1016","volume":"67","author":[{"given":"Viviana","family":"Galimberti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Kahler","family":"Ribeiro Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Vicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Morigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Sargenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Magnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Intra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.breast.2022.12.010_bib1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"32","author":"Lyman","year":"2014","journal-title":"J Clin Oncol."},{"issue":"6","key":"10.1016\/j.breast.2022.12.010_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"Jama."},{"issue":"6","key":"10.1016\/j.breast.2022.12.010_bib3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.breast.2022.12.010_bib4","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2022.12.010_bib5","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial","author":"Bartels","year":"2022","journal-title":"J Clin Oncol."},{"issue":"12","key":"10.1016\/j.breast.2022.12.010_bib6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/bjs.10986","article-title":"Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer","volume":"105","author":"Tee","year":"2018","journal-title":"Br J Surg. Nov"},{"issue":"14","key":"10.1016\/j.breast.2022.12.010_bib7","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA."},{"issue":"7","key":"10.1016\/j.breast.2022.12.010_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.breast.2022.12.010_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","article-title":"Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study","volume":"173","author":"Classe","year":"2019","journal-title":"Breast Cancer Res Treat."},{"issue":"3","key":"10.1016\/j.breast.2022.12.010_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol."},{"issue":"7","key":"10.1016\/j.breast.2022.12.010_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jamasurg.2017.0562","article-title":"Identification of patients with documented pathologic complete response in the breast after neoadjuvant chemotherapy for omission of axillary surgery","volume":"152","author":"Tadros","year":"2017","journal-title":"JAMA Surg"},{"issue":"10","key":"10.1016\/j.breast.2022.12.010_bib12","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1245\/s10434-017-5958-4","article-title":"Use of sentinel lymph node dissection after neoadjuvant chemotherapy in patients with node-positive breast cancer at diagnosis: practice patterns of American society of breast surgeons members","volume":"24","author":"Caudle","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.breast.2022.12.010_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","article-title":"Axillary nodal management following neoadjuvant chemotherapy: a review","volume":"3","author":"Pilewskie","year":"2017","journal-title":"JAMA Oncol."},{"issue":"8","key":"10.1016\/j.breast.2022.12.010_bib14","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1245\/s10434-018-6531-5","article-title":"Neoadjuvant chemotherapy use in breast cancer is greatest in excellent responders: triple-negative and HER2+ subtypes","volume":"25","author":"Murphy","year":"2018","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.breast.2022.12.010_bib15","article-title":"The landmark series: axillary management in breast cancer","author":"Fisher","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.breast.2022.12.010_bib16","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1200\/JCO.2005.05.188","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from national surgical adjuvant breast and bowel project protocol B-27","volume":"23","author":"Mamounas","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.breast.2022.12.010_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.5209","article-title":"Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer","volume":"93","author":"Xing","year":"2006","journal-title":"Br J Surg."},{"issue":"4","key":"10.1016\/j.breast.2022.12.010_bib18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients","volume":"250","author":"Hunt","year":"2009","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.breast.2022.12.010_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jso.21911","article-title":"The feasibility and accuracy of sentinel lymph node biopsy in clinically node-negative patients after neoadjuvant chemotherapy for breast cancer--a systematic review and meta-analysis","volume":"104","author":"Tan","year":"2011","journal-title":"J Surg Oncol"},{"issue":"10","key":"10.1016\/j.breast.2022.12.010_bib20","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1245\/s10434-007-9403-y","article-title":"Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation","volume":"14","author":"Newman","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.breast.2022.12.010_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ejso.2011.05.012","article-title":"Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes","volume":"37","author":"Canavese","year":"2011","journal-title":"Eur J Surg Oncol."},{"issue":"10","key":"10.1016\/j.breast.2022.12.010_bib22","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ejso.2015.07.020","article-title":"The diagnostic performance of sentinel lymph node biopsy in pathologically confirmed node positive breast cancer patients after neoadjuvant systemic therapy: a systematic review and meta-analysis","volume":"41","author":"van Nijnatten","year":"2015","journal-title":"Eur J Surg Oncol."},{"issue":"3","key":"10.1016\/j.breast.2022.12.010_bib23","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/SLA.0000000000003075","article-title":"Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis","volume":"269","author":"Simons","year":"2019","journal-title":"Ann Surg. Mar"},{"issue":"10","key":"10.1016\/j.breast.2022.12.010_bib24","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.annonc.2021.06.023","article-title":"Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021","volume":"32","author":"Burstein","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2022.12.010_bib25","unstructured":"www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed November 2022."},{"issue":"10","key":"10.1016\/j.breast.2022.12.010_bib26","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2022.12.010_bib27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg."},{"issue":"7","key":"10.1016\/j.breast.2022.12.010_bib28","first-page":"13","article-title":"Surgical management of the axilla in clinically node-positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: current status, knowledge gaps, and rationale for the EUBREAST-03 AXSANA study","author":"Banys-Paluchowski","year":"2021","journal-title":"Cancers (basel)"},{"issue":"8","key":"10.1016\/j.breast.2022.12.010_bib29","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1245\/s10434-019-07419-3","article-title":"Pretreatment tattoo marking of suspicious axillary lymph nodes: reliability and correlation with sentinel lymph node","volume":"26","author":"Patel","year":"2019","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"10.1016\/j.breast.2022.12.010_bib30","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0-T4, N1-N2) who receive neoadjuvant chemotherapy: results from ACOSOG Z1071 (alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann Surg."},{"issue":"8","key":"10.1016\/j.breast.2022.12.010_bib31","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1245\/s10434-014-3775-6","article-title":"Implementation of the American college of surgeons oncology group Z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?","volume":"21","author":"Mittendorf","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.breast.2022.12.010_bib32","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.breast.2022.12.010_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejso.2015.11.019","article-title":"Sentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatment","volume":"42","author":"Galimberti","year":"2016","journal-title":"Eur J Surg Oncol."},{"key":"10.1016\/j.breast.2022.12.010_bib34","article-title":"Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up","author":"Kahler-Ribeiro-Fontana","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.breast.2022.12.010_bib35","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1001\/jamaoncol.2021.4394","article-title":"Nodal recurrence in patients with node-positive breast cancer treated with sentinel node biopsy alone after neoadjuvant chemotherapy-A rare event","volume":"7","author":"Barrio","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2022.12.010_bib36","article-title":"Oncologic outcomes of sentinel lymph node surgery after neoadjuvant chemotherapy for node-positive breast cancer","author":"Piltin","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.breast.2022.12.010_bib37","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1245\/s10434-020-09211-0","article-title":"Oncologic safety of sentinel lymph node biopsy alone after neoadjuvant chemotherapy for breast cancer","volume":"28","author":"Wong","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.breast.2022.12.010_bib38","doi-asserted-by":"crossref","first-page":"e544","DOI":"10.1097\/SLA.0000000000004562","article-title":"Sentinel node biopsy alone or with axillary dissection in breast cancer patients after primary chemotherapy: long-term results of a prospective interventional study","volume":"276","author":"Martelli","year":"2022","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.breast.2022.12.010_bib39","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.ejso.2018.05.035","article-title":"Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy","volume":"44","author":"Hartmann","year":"2018","journal-title":"Eur J Surg Oncol."},{"issue":"10","key":"10.1016\/j.breast.2022.12.010_bib40","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1245\/s10434-017-6023-z","article-title":"Localizing the clipped node in patients with node-positive breast cancer treated with neoadjuvant chemotherapy: early learning experience and challenges","volume":"24","author":"Nguyen","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.breast.2022.12.010_bib41","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.2007.15.0326","article-title":"Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference","volume":"26","author":"Buchholz","year":"2008","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.breast.2022.12.010_bib42","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01872975 - Accessed November 2022."},{"key":"10.1016\/j.breast.2022.12.010_bib43","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01901094 - Accessed November 2022."},{"issue":"6","key":"10.1016\/j.breast.2022.12.010_bib44","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrclinonc.2015.63","article-title":"Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy","volume":"12","author":"King","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.breast.2022.12.010_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2019.100496","article-title":"Neonod 2: rationale and design of a multicenter non-inferiority trial to assess the effect of axillary surgery omission on the outcome of breast cancer patients presenting only micrometastasis in the sentinel lymph node after neoadjuvant chemotherapy","volume":"17","author":"Tinterri","year":"2020","journal-title":"Contemp Clin Trials Commun."},{"key":"10.1016\/j.breast.2022.12.010_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(22)00613-1","article-title":"Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial","author":"Kuerer","year":"2022","journal-title":"Lancet Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622002107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622002107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:45:23Z","timestamp":1760777123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977622002107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":46,"alternative-id":["S0960977622002107"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2022.12.010","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cThis house believes that: Sentinel node biopsy alone is better than TAD after NACT for cN+ patients\u201d","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2022.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}